Zhejiang Hengkang Pharmaceutical Co., Ltd. continues to strengthen its position as a leading manufacturer within the global active pharmaceutical ingredient industry, attracting growing attention for ...

Producing active pharmaceutical ingredients (API), raw materials of medicine, is urgent to save the country’s promising pharmaceuticals industry still heavily dependent on imports, industry insiders ...

China and India, which are the largest producers of APIs for the U.S. drug supply, also account for most of the FDA regulatory actions. Not only do quality problems at Chinese and Indian firms raise ...

ST. LOUIS--(BUSINESS WIRE)--The drug API Innovation Center today announced it has reached a milestone in the development of technology essential to accelerating the U.S. production of lomustine, a ...

Bangladesh, a laggard in the production of raw materials for the $3 billion pharmaceuticals industry, has made a four-fold jump in the manufacturing of active pharmaceutical ingredient (API) in the ...

External manufacturing plays a crucial role in pharmaceutical companies’ supply strategy. The author examines market trends for the captive and merchant global market for active pharmaceutical ...

Demand for highly potent APIs continues to rise. Highly potent APIs (HPAPIs) are an increasingly important segment of the API market. While there are many contract development and manufacturing ...